{"name":"Forbion Capital Partners","permalink":"forbion-capital-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/forbion-capital-partners","homepage_url":"http://www.forbion.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+31 (0) 35 699 30 00","description":"","email_address":"info@forbion.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Wed Mar 11 17:44:46 UTC 2009","updated_at":"Wed Sep 08 02:38:59 UTC 2010","overview":"<p>Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbionâ€™s investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed â‚¬400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.</p>","image":{"available_sizes":[[[150,60],"assets/images/resized/0010/0907/100907v1-max-150x150.png"],[[200,80],"assets/images/resized/0010/0907/100907v1-max-250x250.png"],[[200,80],"assets/images/resized/0010/0907/100907v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Gooimeer 2-35","address2":"","zip_code":"1411 DC","city":"Naarden ","state_code":null,"country_code":"NLD","latitude":null,"longitude":null},{"description":"","address1":"Lenbachplatz 3","address2":"4th Floor","zip_code":"80333","city":"MÃ¼nchen","state_code":null,"country_code":"DEU","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Venture Partner","person":{"first_name":"Philip","last_name":"Astley-Sparke","permalink":"philip-astley-sparke-2","image":null}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/01/circulite-completes-325m-series-c.html","source_description":"CircuLite Completes $32.5M Series C Financing","raised_amount":32500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":5,"company":{"name":"CircuLite","permalink":"circulite","image":{"available_sizes":[[[150,41],"assets/images/resized/0003/7780/37780v1-max-150x150.png"],[[175,48],"assets/images/resized/0003/7780/37780v1-max-250x250.png"],[[175,48],"assets/images/resized/0003/7780/37780v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.fiercebiotech.com/story/biovex-raises-40m-series-f/2009-03-30","source_description":"BioVex Raises $40 Million","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":30,"company":{"name":"BioVex","permalink":"biovex","image":{"available_sizes":[[[150,40],"assets/images/resized/0004/9487/49487v2-max-150x150.jpg"],[[250,68],"assets/images/resized/0004/9487/49487v2-max-250x250.jpg"],[[294,80],"assets/images/resized/0004/9487/49487v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://venturebeat.com/2009/03/30/pathway-medical-lands-generous-40m-to-treat-arterial-disease/","source_description":"Pathway Medical lands generous $40M to treat arterial disease","raised_amount":42500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":1,"company":{"name":"Pathway Medical Technologies","permalink":"pathway-medical-technologies","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/1072/41072v1-max-150x150.png"],[[222,56],"assets/images/resized/0004/1072/41072v1-max-250x250.png"],[[222,56],"assets/images/resized/0004/1072/41072v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/argen-x-gins-13-6m-new-funds-mab-work/2009-09-10?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"arGEN-X gins $13.6M in new funds for mAB work","raised_amount":13600000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":10,"company":{"name":"arGEN-X","permalink":"argen-x","image":{"available_sizes":[[[137,56],"assets/images/resized/0005/9706/59706v1-max-150x150.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-250x250.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://stlouis.bizjournals.com/stlouis/stories/2009/08/10/daily23.html","source_description":"NiTi Surgical Solutions raises $18.5M","raised_amount":18500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":11,"company":{"name":"Niti Surgical Solutions","permalink":"niti-surgical-solutions","image":{"available_sizes":[[[150,57],"assets/images/resized/0006/0778/60778v1-max-150x150.png"],[[250,95],"assets/images/resized/0006/0778/60778v1-max-250x250.png"],[[252,96],"assets/images/resized/0006/0778/60778v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/argen-x-bv-series-a-45m/","source_description":"arGEN-X, BV: Series A $4.5M","raised_amount":4500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":11,"company":{"name":"arGEN-X","permalink":"argen-x","image":{"available_sizes":[[[137,56],"assets/images/resized/0005/9706/59706v1-max-150x150.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-250x250.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/genetix-raises-35m-advance-gene-therapies/2010-03-11?utm_medium=rss&utm_source=rss","source_description":"Genetix raises $35M to advance gene therapies","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":12,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.altassets.com/private-equity-news/article/nz18164.html","source_description":"AltAssets","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Promedior","permalink":"promedior","image":{"available_sizes":[[[150,93],"assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.cytheris.com/PDF/CYTHERIS_100607_Series%20D_EN.pdf","source_description":"Cytheris Closes â‚¬12 Million ($15 Million) Series D Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Cytheris","permalink":"cytheris","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/4401/84401v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0008/4401/84401v1-max-250x250.jpg"],[[375,141],"assets/images/resized/0008/4401/84401v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.exosomedx.com/diagnostics_news/news_051110.html","source_description":"Exosome Diagnostics Completes $20 Million Series A Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":11,"company":{"name":"Exosome Diagnostics","permalink":"exosome-diagnostics","image":{"available_sizes":[[[150,56],"assets/images/resized/0009/2826/92826v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0009/2826/92826v1-max-250x250.jpg"],[[306,116],"assets/images/resized/0009/2826/92826v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/09/cardoz-ab-holds-second-close-of-sek124m.html","source_description":"Cardoz AB Holds Second Close of SEK124M Series A Financing","raised_amount":124000000,"raised_currency_code":"SEK","funded_year":2010,"funded_month":9,"funded_day":16,"company":{"name":"Cardoz","permalink":"cardoz","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/01/pneumrx-raises-33m.html","source_description":"PneumRx Raises $33M","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":4,"company":{"name":"PneumRx","permalink":"pneumrx","image":{"available_sizes":[[[150,61],"assets/images/resized/0011/6250/116250v1-max-150x150.png"],[[172,71],"assets/images/resized/0011/6250/116250v1-max-250x250.png"],[[172,71],"assets/images/resized/0011/6250/116250v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.cellnovo.com/CellnovoPressReleaseSeries.pdf","source_description":"CELLNOVO SECURES Â£30 MILLION IN SERIES B FINANCING","raised_amount":30000000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":2,"funded_day":4,"company":{"name":"CellNovo","permalink":"cellnovo","image":{"available_sizes":[[[149,48],"assets/images/resized/0012/0629/120629v1-max-150x150.png"],[[149,48],"assets/images/resized/0012/0629/120629v1-max-250x250.png"],[[149,48],"assets/images/resized/0012/0629/120629v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.live-pr.com/en/bluebird-bio-secures-additional-r1048856638.htm","source_description":"bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":20,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.prnewswire.com/news-releases/amakem-raises-18m-in-a-series-a-round-to-advance-its-ophthalmology-drug-development-programs-129283853.html","source_description":"Amakem Raises â‚¬18m in a Series a Round to Advance its Ophthalmology Drug Development Programs","raised_amount":18000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":9,"funded_day":6,"company":{"name":"Amakem","permalink":"amakem-nv","image":{"available_sizes":[[[150,45],"assets/images/resized/0015/2893/152893v1-max-150x150.jpg"],[[250,75],"assets/images/resized/0015/2893/152893v1-max-250x250.jpg"],[[343,103],"assets/images/resized/0015/2893/152893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/09/gicare-pharma-closes-cad7m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"gIcare Pharma Closes CAD$7M Series A Financing","raised_amount":7000000,"raised_currency_code":"CAD","funded_year":2011,"funded_month":7,"funded_day":21,"company":{"name":"gIcare Pharma","permalink":"gicare-pharma","image":{"available_sizes":[[[148,83],"assets/images/resized/0014/5595/145595v1-max-150x150.png"],[[148,83],"assets/images/resized/0014/5595/145595v1-max-250x250.png"],[[148,83],"assets/images/resized/0014/5595/145595v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/press-releases/hookipa-biotech-closes-7-million-series-financing-led-sofinnova-partners","source_description":"Hookipa Biotech Closes â‚¬7 million Series A Financing led by Sofinnova Partners","raised_amount":7000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":10,"funded_day":18,"company":{"name":"Hookipa Biotech","permalink":"hookipa-biotech","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.curetis.com/fileadmin/curetis/media/struktur/News_Media/Press_Releases/20111026_Curetis_Financing_ENGL_V1.0R_.pdf","source_description":"Series A financing round expended to 34.1 euro","raised_amount":9600000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":10,"funded_day":26,"company":{"name":"Curetis","permalink":"curetis","image":{"available_sizes":[[[150,48],"assets/images/resized/0006/8508/68508v1-max-150x150.jpg"],[[200,64],"assets/images/resized/0006/8508/68508v1-max-250x250.jpg"],[[200,64],"assets/images/resized/0006/8508/68508v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/11/oxyrane-raises-26-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Oxyrane Raises $26.5M in Series D Funding","raised_amount":26500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":17,"company":{"name":"Oxyrane UK","permalink":"oxyrane-uk","image":{"available_sizes":[[[150,38],"assets/images/resized/0016/2877/162877v1-max-150x150.jpg"],[[250,64],"assets/images/resized/0016/2877/162877v1-max-250x250.jpg"],[[257,66],"assets/images/resized/0016/2877/162877v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/11/circulite-raises-30m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CircuLite Raises $30M in Series D Funding","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":30,"company":{"name":"CircuLite","permalink":"circulite","image":{"available_sizes":[[[150,41],"assets/images/resized/0003/7780/37780v1-max-150x150.png"],[[175,48],"assets/images/resized/0003/7780/37780v1-max-250x250.png"],[[175,48],"assets/images/resized/0003/7780/37780v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/12/argen-x-closes-e27-5m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"arGEN-X Closes â‚¬27.5M Series B Funding Round","raised_amount":27500000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":12,"funded_day":1,"company":{"name":"arGEN-X","permalink":"argen-x","image":{"available_sizes":[[[137,56],"assets/images/resized/0005/9706/59706v1-max-150x150.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-250x250.png"],[[137,56],"assets/images/resized/0005/9706/59706v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/promedior-lands-215m-d-round-fibrosis-pipeline/2012-03-07?utm_medium=rss&utm_source=rss","source_description":"Promedior lands $21.5M D round for fibrosis pipeline","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":7,"company":{"name":"Promedior","permalink":"promedior","image":{"available_sizes":[[[150,93],"assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.argostherapeutics.com/news/2012/news_20120424_argosfinancing-FastTrackDesignation_Final.html","source_description":"Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":24,"company":{"name":"Argos Therapeutics","permalink":"argos-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0014/7029/147029v1-max-150x150.png"],[[167,58],"assets/images/resized/0014/7029/147029v1-max-250x250.png"],[[167,58],"assets/images/resized/0014/7029/147029v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/05/mitralign-closes-35m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mitralign Closes $35M in Series D Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":16,"company":{"name":"Mitralign","permalink":"mitralign","image":{"available_sizes":[[[150,63],"assets/images/resized/0019/0150/190150v1-max-150x150.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-250x250.png"],[[184,78],"assets/images/resized/0019/0150/190150v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120621e86lmuwqs&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120621e86lmuwqs%26from%3dalert%26pid%3d32","source_description":"Denmark's Santaris Grabs $12M From Insiders for Clinical Trials ","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":21,"company":{"name":"Santaris Pharma","permalink":"santaris-pharma","image":{"available_sizes":[[[150,61],"assets/images/resized/0019/6720/196720v1-max-150x150.jpg"],[[161,66],"assets/images/resized/0019/6720/196720v1-max-250x250.jpg"],[[161,66],"assets/images/resized/0019/6720/196720v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://in.finance.yahoo.com/news/bluebird-bio-secures-60-million-103000423.html","source_description":"bluebird bio Secures $60 Million in Oversubscribed Financing","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":25,"company":{"name":"bluebird bio","permalink":"genetix-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0169/80169v2-max-150x150.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-250x250.png"],[[226,69],"assets/images/resized/0008/0169/80169v2-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Life sciences investment fund","funded_year":2010,"funded_month":9,"funded_day":7,"raised_amount":313000000,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020100903e697000xd&r=Rss&s=DJFVW","source_description":" Forbion Capital Amasses $313M For Two Health Care Venture Funds"},{"name":"Second fund","funded_year":2011,"funded_month":12,"funded_day":8,"raised_amount":50000000,"raised_currency_code":"USD","source_url":"http://www.businessweek.com/news/2011-12-08/forbion-capital-raises-50-million-to-invest-in-health-companies.html","source_description":"Forbion Capital Raises $50 Million to Invest in Health Companies"}],"video_embeds":[],"external_links":[]}